CAD 0.07
(0.0%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 41.85 Million CAD | 58.38% |
2022 | 26.43 Million CAD | -6.19% |
2021 | 28.17 Million CAD | 139.2% |
2020 | 11.77 Million CAD | 488.31% |
2019 | 2 Million CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
2014 | - CAD | 0.0% |
2013 | - CAD | 0.0% |
2012 | - CAD | 0.0% |
2011 | - CAD | 0.0% |
2010 | - CAD | 0.0% |
2009 | - CAD | 0.0% |
2008 | - CAD | 0.0% |
2007 | - CAD | 0.0% |
2006 | - CAD | 0.0% |
2005 | - CAD | 0.0% |
2004 | - CAD | 0.0% |
2003 | - CAD | 0.0% |
2002 | - CAD | 0.0% |
2001 | - CAD | 0.0% |
2000 | - CAD | 0.0% |
1999 | - CAD | 0.0% |
1998 | - CAD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 4.33 Million CAD | -40.4% |
2024 Q2 | 4.31 Million CAD | 103.11% |
2023 Q2 | 8.37 Million CAD | -11.35% |
2023 Q4 | 7.27 Million CAD | -42.87% |
2023 Q3 | 12.72 Million CAD | 51.96% |
2023 FY | 26.2 Million CAD | -0.87% |
2023 Q1 | 9.44 Million CAD | 53.73% |
2022 Q1 | 3.1 Million CAD | -61.94% |
2022 Q3 | 11.69 Million CAD | 113.08% |
2022 Q4 | 6.14 Million CAD | -47.44% |
2022 FY | 26.43 Million CAD | -6.19% |
2022 Q2 | 5.48 Million CAD | 76.86% |
2021 Q1 | 8.47 Million CAD | 82.96% |
2021 Q4 | 8.15 Million CAD | 58.72% |
2021 FY | 28.17 Million CAD | 139.2% |
2021 Q3 | 5.13 Million CAD | -19.93% |
2021 Q2 | 6.41 Million CAD | -24.28% |
2020 Q3 | 3.06 Million CAD | 58.53% |
2020 FY | 11.77 Million CAD | 488.31% |
2020 Q4 | 4.63 Million CAD | 51.01% |
2020 Q1 | 2.14 Million CAD | 120.31% |
2020 Q2 | 1.93 Million CAD | -9.96% |
2019 Q3 | 642 Thousand CAD | 78.83% |
2019 Q1 | 26 Thousand CAD | 0.0% |
2019 Q2 | 359 Thousand CAD | 1280.77% |
2019 FY | 2 Million CAD | 0.0% |
2019 Q4 | 975 Thousand CAD | 51.87% |
2018 Q1 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2015 Q1 | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
2015 Q4 | - CAD | 0.0% |
2015 Q2 | - CAD | 0.0% |
2014 Q2 | - CAD | 0.0% |
2014 Q3 | - CAD | 0.0% |
2014 Q1 | - CAD | 0.0% |
2014 Q4 | - CAD | 0.0% |
2014 FY | - CAD | 0.0% |
2013 Q4 | - CAD | 0.0% |
2013 FY | - CAD | 0.0% |
2013 Q2 | - CAD | 0.0% |
2013 Q3 | - CAD | 0.0% |
2013 Q1 | - CAD | 0.0% |
2012 Q3 | - CAD | 0.0% |
2012 Q1 | - CAD | 0.0% |
2012 FY | - CAD | 0.0% |
2012 Q4 | - CAD | 0.0% |
2012 Q2 | - CAD | 0.0% |
2011 FY | - CAD | 0.0% |
2011 Q4 | - CAD | 0.0% |
2011 Q3 | - CAD | 0.0% |
2011 Q2 | - CAD | 0.0% |
2011 Q1 | - CAD | 0.0% |
2010 Q4 | - CAD | 0.0% |
2010 Q3 | - CAD | 0.0% |
2010 FY | - CAD | 0.0% |
2010 Q2 | - CAD | 0.0% |
2010 Q1 | - CAD | 0.0% |
2009 Q3 | - CAD | 0.0% |
2009 FY | - CAD | 0.0% |
2009 Q4 | - CAD | 0.0% |
2009 Q2 | - CAD | 0.0% |
2009 Q1 | - CAD | 0.0% |
2008 FY | - CAD | 0.0% |
2008 Q1 | - CAD | 0.0% |
2008 Q2 | - CAD | 0.0% |
2008 Q3 | - CAD | 0.0% |
2008 Q4 | - CAD | 0.0% |
2007 Q3 | - CAD | 0.0% |
2007 Q4 | - CAD | 0.0% |
2007 Q2 | - CAD | 0.0% |
2007 Q1 | - CAD | 0.0% |
2007 FY | - CAD | 0.0% |
2006 Q2 | - CAD | 0.0% |
2006 Q3 | - CAD | 0.0% |
2006 Q1 | - CAD | 0.0% |
2006 FY | - CAD | 0.0% |
2006 Q4 | - CAD | 0.0% |
2005 Q4 | - CAD | 0.0% |
2005 Q1 | - CAD | 0.0% |
2005 Q3 | - CAD | 0.0% |
2005 Q2 | - CAD | 0.0% |
2005 FY | - CAD | 0.0% |
2004 Q2 | - CAD | 0.0% |
2004 Q4 | - CAD | 0.0% |
2004 Q3 | - CAD | 0.0% |
2004 FY | - CAD | 0.0% |
2004 Q1 | - CAD | 0.0% |
2003 Q3 | - CAD | 0.0% |
2003 FY | - CAD | 0.0% |
2003 Q4 | - CAD | 0.0% |
2003 Q1 | - CAD | 0.0% |
2003 Q2 | - CAD | 0.0% |
2002 Q4 | - CAD | 0.0% |
2002 Q3 | - CAD | 0.0% |
2002 Q1 | - CAD | 0.0% |
2002 FY | - CAD | 0.0% |
2002 Q2 | - CAD | 0.0% |
2001 Q4 | - CAD | 0.0% |
2001 Q3 | - CAD | 0.0% |
2001 Q2 | - CAD | 0.0% |
2001 Q1 | - CAD | 0.0% |
2001 FY | - CAD | 0.0% |
2000 FY | - CAD | 0.0% |
2000 Q2 | - CAD | 0.0% |
2000 Q3 | - CAD | 0.0% |
2000 Q1 | - CAD | 0.0% |
1999 FY | - CAD | 0.0% |
1999 Q3 | - CAD | 0.0% |
1998 FY | - CAD | 0.0% |
1998 Q3 | - CAD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 5499.00 CAD | -761111.129% |
CanadaBis Capital Inc. | 11.78 Million CAD | -255.228% |
Delivra Health Brands Inc. | 6.39 Million CAD | -554.149% |
Entourage Health Corp. | 3.7 Million CAD | -1028.975% |
Lifeist Wellness Inc. | 5.34 Million CAD | -683.248% |
Cannara Biotech Inc. | 27.23 Million CAD | -53.72% |
Medicure Inc. | 13.98 Million CAD | -199.228% |
PharmaCielo Ltd. | -1.36 Million CAD | 3157.997% |
Rubicon Organics Inc. | 13.14 Million CAD | -218.543% |
BioSyent Inc. | 25.14 Million CAD | -66.486% |
Voyageur Pharmaceuticals Ltd. | -2185.00 CAD | 1915843.707% |